
Zydus Lifesciences Ltd. share price
NSE: ZYDUSLIFE · Healthcare
₹1,192.00 +0.18%
Closing price data, updated 17 Nov 2026. 52-week range: -5.9% from high, +42.7% above low.
Price₹1,192.00
Market cap₹1,18,902 Cr
P/E28.4
P/B4.27
ROE19.7%
ROCE19.0%
Debt / equity0.46
Dividend yield0.00%
EPS₹41.90
Book value₹278.87
Operating margin21.7%
Dipscan score63 / 100
Share: WhatsAppX / TwitterTelegram
Zydus Lifesciences Ltd. shareholding pattern
As of Sep 2026: Promoters 75.01%, FIIs 7.05%, DIIs 11.28%, Government 0.00%, Public 5.30%, Others 1.36%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 75.01% | 75.01% | 75.00% | 75.00% | 74.99% | 74.99% |
| FIIs | 7.05% | 6.88% | 6.95% | 7.06% | 7.34% | 7.13% |
| DIIs | 11.28% | 11.27% | 11.20% | 11.09% | 10.86% | 11.13% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 5.30% | 5.45% | 5.54% | 5.54% | 5.49% | 5.46% |
| Others | 1.36% | 1.38% | 1.32% | 1.31% | 1.32% | 1.28% |
| No. of Shareholders | 382,067 | 403,889 | 418,314 | 403,266 | 396,105 | 386,127 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +0.18% | -0.49% | +5.98% | +2.12% | +20.20% | +26.96% |
Growth
| Sales growth, 3 years | +16.6% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +37.0% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | – |
| Latest quarter profit vs last year | -26.6% |
Strengths and weaknesses
Strengths
- Company has delivered good profit growth of 18.8% CAGR over last 5 years
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
| Mankind Pharma Ltd. | ₹2,626.60 | ₹1,08,490 Cr | 48.4 | 12.5% | +18.3% |
Frequently asked questions
What is the share price of Zydus Lifesciences Ltd.?
Zydus Lifesciences Ltd. (ZYDUSLIFE) last closed at ₹1,192.00 (+0.18% on the day).
What is the market cap of Zydus Lifesciences Ltd.?
About ₹1,18,902 Cr.
What is the P/E ratio of Zydus Lifesciences Ltd.?
The price-to-earnings ratio is 28.4, and return on equity is 19.7%.
Figures are calculated from company results and exchange prices and are for information only.